Fortis Healthcare Limited

14.8%

y 07, 2025 Fortis Healthcare announces Q3 FY25 Financial Results Consolidated Revenues increase 14.8% to INR 1,928 Cr; Operating EBITDA up 32.0% to INR 375 Cr, 19.4% Margin (vs Q3FY24 at 16.9%) Hosp

INR 1,928

5 Fortis Healthcare announces Q3 FY25 Financial Results Consolidated Revenues increase 14.8% to INR 1,928 Cr; Operating EBITDA up 32.0% to INR 375 Cr, 19.4% Margin (vs Q3FY24 at 16.9%) Hospital Business

32.0%

FY25 Financial Results Consolidated Revenues increase 14.8% to INR 1,928 Cr; Operating EBITDA up 32.0% to INR 375 Cr, 19.4% Margin (vs Q3FY24 at 16.9%) Hospital Business Revenues increase 16.8% to IN

INR 375

ncial Results Consolidated Revenues increase 14.8% to INR 1,928 Cr; Operating EBITDA up 32.0% to INR 375 Cr, 19.4% Margin (vs Q3FY24 at 16.9%) Hospital Business Revenues increase 16.8% to INR 1,623 Cr; O

19.4%

s Consolidated Revenues increase 14.8% to INR 1,928 Cr; Operating EBITDA up 32.0% to INR 375 Cr, 19.4% Margin (vs Q3FY24 at 16.9%) Hospital Business Revenues increase 16.8% to INR 1,623 Cr; Operating

16.9%

ncrease 14.8% to INR 1,928 Cr; Operating EBITDA up 32.0% to INR 375 Cr, 19.4% Margin (vs Q3FY24 at 16.9%) Hospital Business Revenues increase 16.8% to INR 1,623 Cr; Operating EBITDA up 29.8% to INR 325

16.8%

DA up 32.0% to INR 375 Cr, 19.4% Margin (vs Q3FY24 at 16.9%) Hospital Business Revenues increase 16.8% to INR 1,623 Cr; Operating EBITDA up 29.8% to INR 325 Cr, 20.0% Margin (vs Q3FY24 at 18.0%) Comp

INR 1,623

0% to INR 375 Cr, 19.4% Margin (vs Q3FY24 at 16.9%) Hospital Business Revenues increase 16.8% to INR 1,623 Cr; Operating EBITDA up 29.8% to INR 325 Cr, 20.0% Margin (vs Q3FY24 at 18.0%) Company consolidat

29.8%

Q3FY24 at 16.9%) Hospital Business Revenues increase 16.8% to INR 1,623 Cr; Operating EBITDA up 29.8% to INR 325 Cr, 20.0% Margin (vs Q3FY24 at 18.0%) Company consolidates its stake in Agilus Diagnos

INR 325

t 16.9%) Hospital Business Revenues increase 16.8% to INR 1,623 Cr; Operating EBITDA up 29.8% to INR 325 Cr, 20.0% Margin (vs Q3FY24 at 18.0%) Company consolidates its stake in Agilus Diagnostics Limited

20.0%

ospital Business Revenues increase 16.8% to INR 1,623 Cr; Operating EBITDA up 29.8% to INR 325 Cr, 20.0% Margin (vs Q3FY24 at 18.0%) Company consolidates its stake in Agilus Diagnostics Limited from 57.

18.0%

ncrease 16.8% to INR 1,623 Cr; Operating EBITDA up 29.8% to INR 325 Cr, 20.0% Margin (vs Q3FY24 at 18.0%) Company consolidates its stake in Agilus Diagnostics Limited from 57.68% to 89.20% Gurugram, F

“By attending or assessing this presentation you acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.”

“Performance Highlights • Earnings and Financial Summary – Q3 FY25 and 9M FY25 3.”

“Q3FY24 Q2FY25 Q3FY25 Up 9.9% 16 Q3FY25 DIAGNOSTIC BUSINESS HIGHLIGHTS • Agilus reported gross revenue of INR 342.3 Cr in Q3 FY25 as compared to INR 330.7 Cr in Q3FY24, resulting in YoY growth of 3.5%.”

“Capacity of ~200 beds has been added across Manesar, Shalimar Bagh, Anandpur, NagarBhavi in 9MFY25; an additional capacity of ~70 beds will be added in FMRI and Faridabad in Q4FY25 27 PERFORMANCE REVIEW DIAGNOSTICS BUSINESS 28 DIAGNOSTICS BUSINESS • During Q3FY25, Agilus conducted 10.29 Mn tests, versus 9.85 Mn in Q3FY24.”

Cash

2

For further details please contact

1

For further details please contact

Anurag Kalra / Amit Mahendru Investor Relations +91-9810109253 / +91-9891094323 Fortis Healthcare Limited Ajey Maharaj Corporate Communication +91-9871798573 Fortis Healthcare Limited 3 FORTIS HEALTHCARE LIMITED EARNINGS PRESENTATION – Q3 FY25 and 9M FY25 February 07, 2025 1 About Fortis Healthcare Punjab ➢ Mohali ➢ Ludhiana ➢ Ludhiana 2 ➢ Amritsar 772 Rajasthan Jaipur 275 Maharashtra ➢ Mulund ➢ Vashi ➢ Kalyan ➢ SL Raheja (O&M) 770 581 Karnataka Bengaluru ➢ BG Road ➢ CG Road ➢ NagarBhavi ➢ Rajaji Nagar 1,853 National Capital Region ➢ FMRI, Gurugram ➢ FEHI, New Delhi ➢ Shalimar Bagh ➢ Noida ➢ Vasant Kunj (O&M) ➢ Faridabad ➢ Manesar, Gurugram ➢ La Femme GK ➢ Def Col ➢ C-DOC (O&M) ➢ Greater Noida (O&M) 372 West Bengal Kolkata ➢ Anandpur ➢ FHKI & FMC Chhattisgarh ➢ Raigarh (O&M) 70 27 Healthcare Facilities* ~4,700 Operational Beds^ 6,850+ Doctors 6,600+ Nurses 23,000+ employees (including Agilus) 4 JCI Accredited 24 NABH Accredited/ Certified Amongst the most accredited healthcare network

Cash

Domestic, 35.8% Pvt Corps, 0.8% Govt & PSUs, 8.5% CGHS, 4.1% ECHS, 7.1% International , 7.7% Govt & PSUs, 8.8% CGHS, 4.6% ECHS, 7.7% Pvt Corps, 1.0%

Cash

Domestic, 33.9% International , 7.7% 23 HOSPITAL BUSINESS PERFORMANCE – Q3FY25 All the key healthcare facilities continue to witness a YoY upward momentum in revenues Revenue Q3FY24 Q3FY25 245 195 203 171 163 124 127 132 131 120 128 106 122 101 All figures in INR Cr. 85 75 56 60 60 48 FMRI Mohali Shalimar Bagh BG Road Noida Mulund FEHI Anandpur Jaipur Faridabad Revenue Q2FY25 Q3FY25 251 245 207 203 156 163 148 132 136 131 128 128 120 122 All figures in INR Cr. 90 85 59 60 59 60 FMRI Mohali Shalimar Bagh BG Road Noida Mulund FEHI Anandpur Jaipur Faridabad 24 HOSPITAL MARGIN MATRIX EBITDA No of Facilities Revenue Contribution Operational beds ARPOB (INR Cr) Occupancy >20% 15% - 20% 10% - 15% <10% 11 2 3 5^ 74.3% 6.4% 4.4% 13.6% 2,658 379 201 830 2.61 1.48 2.53 1.96 72% 77% 57% 58% ^ Note: <10% EBITDA Margin facilities include Ludhiana 2 (commissioned in Dec’23) and Manesar (commissioned in Sep’24) EBITDA No of Facilities Revenue Contribution Operational beds ARPOB (INR Cr) Occupancy 20%